Spiros Garbis's Biography

• Home
• |
• Register
• |
• Submissions
  • Submission Guidelines
  • Submissions
• |
• Agenda
  • Keynote Speakers
  • Agenda Day 1
  • Agenda Day 2
• |
• Exhibition
• |
• Venue
• |
• Media
  • Media Partners
• |
• Short Courses
  • Business Courses
  • Workshops
• |
• Posters
  • Submission Guidelines
  • Submissions
• |

The Use of Multi-dimensional Proteomics in Cancer Biomarker Discovery

Friday, 11 May 2012 at 11:15

Add to Calendar ▼2012-05-11 11:15:002012-05-11 12:15:00Europe/LondonThe Use of Multi-dimensional Proteomics in Cancer Biomarker Discovery SELECTBIOenquiries@selectbiosciences.com

Advancements made to sample preparation, biomolecular separation along with technological improvements to various mass spectrometry designs, now allows identification and quantification of dynamic proteomes derived from complex biomedical specimens with very high sensitivity and accuracy. Thanks to the proteomic methods developed in our group, it is now possible to detect and quantify tissue specific proteins in serum at levels that meet or exceed the detection limits of the ELISA assay. Here we will show representative data from breast and prostate cancer.